date,title,source
Oct-18-18,"Agios to Webcast Conference Call of Third Quarter 2018 Financial Results on November 1, 2018",GlobeNewswire
Oct-19-18,Agios Rides on Tibsovo Approval Amid Reliance on Celgene,Zacks
Nov-01-18,Edited Transcript of AGIO earnings conference call or presentation 1-Nov-18 12:00pm GMT,Thomson Reuters StreetEvents
Nov-01-18,"Agios Pharmaceuticals (AGIO) Reports Q3 Loss, Tops Revenue Estimates",Zacks
Nov-01-18,Agios to Present Updated Clinical Data at the 2018 ASH Annual Meeting,GlobeNewswire
Nov-01-18,Agios Pharmaceuticals: 3Q Earnings Snapshot,Associated Press
Nov-01-18,Today's Research Reports on Trending Tickers: Agios Pharmaceuticals and Incyte,ACCESSWIRE
Nov-01-18,Agios Reports Third Quarter 2018 Financial Results,GlobeNewswire
Nov-08-18,"New Research Coverage Highlights John B. Sanfilippo & Son, Axcelis Technologies, Cogent Communications, Star Bulk Carriers, Agios Pharmaceuticals, and MDC Partners  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Nov-08-18,3 Biotech Stocks Poised for Big Rebounds,Investopedia
Nov-14-18,Today's Research Reports on Trending Tickers: Exelixis and Agios Pharmaceuticals,ACCESSWIRE
Nov-16-18,Agios Presents Updated Data from Phase 1 Dose-Escalation Study of AG-881 in Patients with IDH Mutant Positive Advanced Glioma,GlobeNewswire
Nov-19-18,Edited Transcript of AGIO earnings conference call or presentation 1-Nov-18 12:00pm GMT,Thomson Reuters StreetEvents
Nov-26-18,Today's Research Reports on Trending Tickers: Agios Pharmaceuticals and Amarin Corporation,ACCESSWIRE
Dec-03-18,Agios Presents Updated Data from the Ivosidenib Phase 1 Dose-Escalation and Expansion Trial in IDH1 Mutant Positive Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Ineligible for Standard Treatment and Myelodysplastic Syndrome (MDS),GlobeNewswire
Dec-03-18,Agios Announces Updated Data from Phase 1 Study of Ivosidenib or Enasidenib in Combination with Standard Induction and Consolidation Chemotherapy in Newly Diagnosed AML Patients With an IDH Mutation,GlobeNewswire
Dec-03-18,Today's Research Reports on Trending Tickers: Agios Pharmaceuticals and Exelixis,ACCESSWIRE
Dec-07-18,Today's Research Reports on Trending Tickers: Amarin Corporation and Agios Pharmaceuticals,ACCESSWIRE
Dec-12-18,Today's Research Reports on Trending Tickers: Arrowhead Pharmaceuticals and Agios Pharmaceuticals,ACCESSWIRE
Dec-13-18,"Market Trends Toward New Normal in DXC Technology, Patterson Companies, Lumentum, DSW, Agios Pharmaceuticals, and Six Flags Entertainment Corporation New  Emerging Consolidated Expectations, Analyst Ratings",GlobeNewswire
Dec-13-18,Hedge Funds Are Selling Agios Pharmaceuticals Inc (AGIO),Insider Monkey
Dec-14-18,"Our Take On Agios Pharmaceuticals, Inc.s (NASDAQ:AGIO) CEO Salary",Simply Wall St.
Dec-28-18,"Agios to Present at the 37th Annual J.P. Morgan Healthcare Conference on Monday, January 7, 2019",GlobeNewswire
Jan-07-19,Agios Highlights Key 2019 Initiatives to Broaden Potential for Cancer and Rare Genetic Disease Programs to Build Long-Term Value,GlobeNewswire
Jan-10-19,5 Biotech Stocks That Could Face M&A Next!,InvestorPlace
Jan-29-19,"Have Insiders Been Selling Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Shares?",Simply Wall St.
